90 related articles for article (PubMed ID: 35599603)
1. SLC8A1 antisense RNA 1 suppresses papillary thyroid cancer malignant progression via the FUS RNA binding protein (FUS)/NUMB like endocytic adaptor protein (Numbl) axis.
Xin Y; Shang X; Sun X; Xu G; Liu Y; Liu Y
Bioengineered; 2022 May; 13(5):12572-12582. PubMed ID: 35599603
[TBL] [Abstract][Full Text] [Related]
2. LncRNA SOCS2-AS1 promotes the progression of papillary thyroid cancer by destabilizing p53 protein.
Zhang X; Zhang X; Yang G; Wan L; Yin F; Li H; Yin D
Biochem Biophys Res Commun; 2023 Aug; 669():95-102. PubMed ID: 37267865
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA MFSD4A-AS1 promotes lymphangiogenesis and lymphatic metastasis of papillary thyroid cancer.
Liu X; Zhang C; Wang X; Cui C; Cui H; Zhu B; Chen A; Zhang L; Xin J; Fu Q; Dionigi G; Sun H
Endocr Relat Cancer; 2023 Mar; 30(3):. PubMed ID: 36606578
[TBL] [Abstract][Full Text] [Related]
4. LncRNA ZNF503-AS1 acts as a tumor suppressor in bladder cancer by up-regulating Ca
He H; Wu S; Ai K; Xu R; Zhong Z; Wang Y; Zhang L; Zhao X; Zhu X
Cell Oncol (Dordr); 2021 Feb; 44(1):219-233. PubMed ID: 33001357
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA ACTA2-AS1 suppresses metastasis of papillary thyroid cancer via regulation of miR-4428/KLF9 axis.
Wu S; Zhu J; Jiang T; Cui T; Zuo Q; Zheng G; Li G; Zhou J; Chen X
Clin Epigenetics; 2024 Jan; 16(1):10. PubMed ID: 38195623
[TBL] [Abstract][Full Text] [Related]
6. Fasting regulates mitochondrial function through lncRNA PRKCQ-AS1-mediated IGF2BPs in papillary thyroid carcinoma.
Zhang X; Zhong Y; Liu L; Jia C; Cai H; Yang J; Wu B; Lv Z
Cell Death Dis; 2023 Dec; 14(12):827. PubMed ID: 38092752
[TBL] [Abstract][Full Text] [Related]
7. LncRNA ABHD11-AS1 activates EGFR signaling to promote cervical cancer progression by preventing FUS-mediated degradation of ABHD11 mRNA.
Yang T; Tian S; Zhao J; Pei M; Zhao M; Yang X
Cell Cycle; 2023; 22(23-24):2538-2551. PubMed ID: 38146687
[TBL] [Abstract][Full Text] [Related]
8. LINC00641 impeded the malignant biological behaviors of papillary thyroid carcinoma cells via interacting with IGF2BP1 to reduce GLI1 mRNA stability.
Meng D; Zhao S; Wu L; Ma X; Zhao D; Li Z
Hum Exp Toxicol; 2023; 42():9603271231180856. PubMed ID: 37291850
[TBL] [Abstract][Full Text] [Related]
9. Delving into the Role of lncRNAs in Papillary Thyroid Cancer: Upregulation of LINC00887 Promotes Cell Proliferation, Growth and Invasion.
Tous C; Muñoz-Redondo C; Gavilán A; Bravo-Gil N; Baco-Antón F; Navarro-González E; Antiñolo G; Borrego S
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338866
[TBL] [Abstract][Full Text] [Related]
10. Identification of immune-related lncRNAs to improve the prognosis prediction for patients with papillary thyroid cancer.
Li Z; Lin W; Zheng J; Hong W; Zou J; Zhang T; Chen Y; Lu H
Biosci Rep; 2021 Feb; 41(2):. PubMed ID: 33554245
[TBL] [Abstract][Full Text] [Related]
11. KIF26B-AS1 Regulates TLR4 and Activates the TLR4 Signaling Pathway to Promote Malignant Progression of Laryngeal Cancer.
Li L; Han J; Zhang S; Dong C; Xiao X
J Microbiol Biotechnol; 2022 Oct; 32(10):1344-1354. PubMed ID: 36224753
[TBL] [Abstract][Full Text] [Related]
12. Single-cell sequencing reveals SATB2/NOTCH1 signaling promotes the progression of malignancy of epithelial cells from papillary thyroid cancer.
Zhang W; Wang J; Huang D; Liu Z; Lu T; Cui C; Li Z
Mol Carcinog; 2024 Jan; 63(1):22-33. PubMed ID: 37877736
[TBL] [Abstract][Full Text] [Related]
13. RNF150 suppresses papillary thyroid carcinoma with ASK1 ubiquitination presenting a direct target via inactivating p38 signaling axis.
Deng W; Wu J; Zheng W; Wang Q; Li D; Kuang H
Cell Biol Int; 2023 Jul; 47(7):1198-1208. PubMed ID: 36950779
[TBL] [Abstract][Full Text] [Related]
14. LncRNA GLTC targets LDHA for succinylation and enzymatic activity to promote progression and radioiodine resistance in papillary thyroid cancer.
Shi L; Duan R; Sun Z; Jia Q; Wu W; Wang F; Liu J; Zhang H; Xue X
Cell Death Differ; 2023 Jun; 30(6):1517-1532. PubMed ID: 37031273
[TBL] [Abstract][Full Text] [Related]
15. Use of long non-coding RNAs for the molecular diagnosis of papillary thyroid cancer.
Kim D; Yu J; Kim J; Hwang YA; Kim JK; Ku CR; Yoon JH; Kwak JY; Nam KH; Lee EJ
Front Oncol; 2022; 12():924409. PubMed ID: 36132147
[TBL] [Abstract][Full Text] [Related]
16. LMNTD2-AS1 regulates immune cell infiltration and promotes prostate cancer progression by targeting FUS to regulate NRF2 signal pathway.
Wu H; Liu N; He A; Li H; Liu H; Qian J; Mao W; Fu G
Am J Cancer Res; 2023; 13(8):3384-3400. PubMed ID: 37693143
[TBL] [Abstract][Full Text] [Related]
17. The Prognostic Value and Potential Immune Mechanisms of lncRNAs Related to Immunogenic Cell Death in Papillary Thyroid Carcinoma.
Wang Y; Li X; Huang Y; Gang Q; Liu M; Zhang H; Shen S; Qi Y; Zhang J
J Inflamm Res; 2024; 17():1995-2008. PubMed ID: 38566983
[TBL] [Abstract][Full Text] [Related]
18. FUS-Mediated CircFGFR1 Accelerates the Development of Papillary Thyroid Carcinoma by Stabilizing FGFR1 Protein.
Zheng L; Tang T; Wang Z; Sun C; Chen X; Li W; Wang B
Biochem Genet; 2024 Jan; ():. PubMed ID: 38261157
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive pan-cancer analysis of expression profiles and prognostic significance for NUMB and NUMBL in human tumors.
Zhang Y; Yang H; Liu W; Song Q; Li Y; Zhang J; Zhou D; Li A
Medicine (Baltimore); 2023 Sep; 102(35):e34717. PubMed ID: 37657045
[TBL] [Abstract][Full Text] [Related]
20. Circular RNA SLC8A1 triggers hippocampal neuronal ferroptosis by regulating FUS-mediated ATF3 mRNA stability in epilepsy.
Kang Q; Zhang J; Xie C; Fang S; Chai W
Exp Cell Res; 2024 Jan; 434(1):113848. PubMed ID: 37918704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
